APP and Alzheimer disease: In a transgenic AD mouse model, it was found that long-term administration (i.e., sixteen months) of Ginkgo biloba extracts considerably decreased the levels of APP, further proposing the potential neuroprotective properties of these extracts associated to APP-reducing activities [124].